Literature DB >> 19214394

Interactions between canthaxanthin and lipid membranes--possible mechanisms of canthaxanthin toxicity.

Agnieszka Sujak1.   

Abstract

Canthaxanthin (beta, beta-carotene 4, 4' dione) is used widely as a drug or as a food and cosmetic colorant, but it may have some undesirable effects on human health, mainly caused by the formation of crystals in the macula lutea membranes of the retina. This condition is called canthaxanthin retinopathy. It has been shown that this type of dysfunction of the eye is strongly connected with damage to the blood vessels around the place of crystal deposition. This paper is a review of the experimental data supporting the hypothesis that the interactions of canthaxanthin with the lipid membranes and the aggregation of this pigment may be the factors enhancing canthaxanthin toxicity towards the macula vascular system. All the results of the experiments that have been done on model systems such as monolayers of pure canthaxanthin and mixtures of canthaxanthin and lipids, oriented bilayers or liposomes indicate a very strong effect of canthaxanthin on the physical properties of lipid membranes, which may explain its toxic action, which leads to the further development of canthaxanthin retinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214394      PMCID: PMC6275664          DOI: 10.2478/s11658-009-0010-8

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  57 in total

Review 1.  Ocular adverse reactions to tamoxifen--a review.

Authors:  P Dulley
Journal:  Ophthalmic Physiol Opt       Date:  1999-03       Impact factor: 3.117

2.  Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina.

Authors:  A Y Yemelyanov; N B Katz; P S Bernstein
Journal:  Exp Eye Res       Date:  2001-04       Impact factor: 3.467

3.  Acute toxic effects of chloroquine on the cat retina.

Authors:  E L Berson
Journal:  Invest Ophthalmol       Date:  1970-08

4.  Canthaxanthin--the "tanning" pill.

Authors:  C W Lober
Journal:  J Am Acad Dermatol       Date:  1985-10       Impact factor: 11.527

5.  Gold dust retinopathy after the ingestion of canthaxanthine to produce skin-bronzing.

Authors:  R McGuinness; P Beaumont
Journal:  Med J Aust       Date:  1985 Dec 9-23       Impact factor: 7.738

6.  Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.

Authors:  P S Bernstein; F Khachik; L S Carvalho; G J Muir; D Y Zhao; N B Katz
Journal:  Exp Eye Res       Date:  2001-03       Impact factor: 3.467

7.  A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo.

Authors:  B P Chew; J S Park; M W Wong; T S Wong
Journal:  Anticancer Res       Date:  1999 May-Jun       Impact factor: 2.480

8.  Monitoring of patients taking canthaxanthin and carotene: an electroretinographic and ophthalmological survey.

Authors:  G B Arden; J O Oluwole; P Polkinghorne; A C Bird; F M Barker; P G Norris; J L Hawk
Journal:  Hum Toxicol       Date:  1989-11

9.  Carotenoids in the human macula and whole retina.

Authors:  G J Handelman; E A Dratz; C C Reay; J G van Kuijk
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-06       Impact factor: 4.799

10.  [Canthaxanthin retinopathy without intake of canthaxanthin].

Authors:  J A Oosterhuis; H Remky; N M Nijman; A Craandijk; F A de Wolff
Journal:  Klin Monbl Augenheilkd       Date:  1989-02       Impact factor: 0.700

View more
  3 in total

1.  Cellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor.

Authors:  Damon Barbacci; Shelley N Jackson; Ludovic Muller; Thomas Egan; Ernest K Lewis; J Albert Schultz; Amina S Woods
Journal:  J Proteome Res       Date:  2012-04-30       Impact factor: 4.466

Review 2.  Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases.

Authors:  Zhong-Wei Zhang; Xiao-Chao Xu; Ting Liu; Shu Yuan
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

3.  Canthaxanthin retinopathy with visual loss: a case report and review.

Authors:  Robert A Beaulieu; Ronald E Warwar; Bruce M Buerk
Journal:  Case Rep Ophthalmol Med       Date:  2013-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.